OneSource Specialty Pharma received a USFDA inspection VAI status for its Bengaluru sterile injectables unit on 30 October. The report follows an inspection of the...
OneSource Specialty Pharma shares fell 7% before recovering sharply, hit by a supply delay at key client Dr Reddy’s Laboratories. The disruption traces back to...